Inadomi JM - Search Results

1

Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.

El-Serag HB, Lee P, Buchner A, Inadomi JM, Gavin M, McCarthy DM. El-Serag HB, et al. Among authors: inadomi jm. Am J Gastroenterol. 2001 Apr;96(4):979-83. doi: 10.1111/j.1572-0241.2001.03681.x. Am J Gastroenterol. 2001. PMID: 11316215 Free article. Clinical Trial.

2

The impact of peptic ulcer disease and infection with Helicobacter pylori on life expectancy.

Inadomi JM, Sonnenberg A. Inadomi JM, et al. Am J Gastroenterol. 1998 Aug;93(8):1286-90. doi: 10.1111/j.1572-0241.1998.00410.x. Am J Gastroenterol. 1998. PMID: 9707052

3

Corpus gastritis is protective against reflux oesophagitis.

El-Serag HB, Sonnenberg A, Jamal MM, Inadomi JM, Crooks LA, Feddersen RM. El-Serag HB, et al. Among authors: inadomi jm. Gut. 1999 Aug;45(2):181-5. doi: 10.1136/gut.45.2.181. Gut. 1999. PMID: 10403728 Free PMC article.

4

Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis.

El-Serag HB, Inadomi JM, Kowdley KV. El-Serag HB, et al. Among authors: inadomi jm. Ann Intern Med. 2000 Feb 15;132(4):261-9. doi: 10.7326/0003-4819-132-4-200002150-00003. Ann Intern Med. 2000. PMID: 10681280 Free article.

5

Step-down management of gastroesophageal reflux disease.

Inadomi JM, Jamal R, Murata GH, Hoffman RM, Lavezo LA, Vigil JM, Swanson KM, Sonnenberg A. Inadomi JM, et al. Gastroenterology. 2001 Nov;121(5):1095-100. doi: 10.1053/gast.2001.28649. Gastroenterology. 2001. PMID: 11677201

6

Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.

El-Serag HB, Graham DY, Richardson P, Inadomi JM. El-Serag HB, et al. Among authors: inadomi jm. Arch Intern Med. 2002 Oct 14;162(18):2105-10. doi: 10.1001/archinte.162.18.2105. Arch Intern Med. 2002. PMID: 12374519

7

Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.

Inadomi JM, McIntyre L, Bernard L, Fendrick AM. Inadomi JM, et al. Am J Gastroenterol. 2003 Sep;98(9):1940-4. doi: 10.1111/j.1572-0241.2003.07665.x. Am J Gastroenterol. 2003. PMID: 14499769 Free article. Clinical Trial.

8

On-demand therapy for gastroesophageal reflux disease.

Metz DC, Inadomi JM, Howden CW, van Zanten SJ, Bytzer P. Metz DC, et al. Among authors: inadomi jm. Am J Gastroenterol. 2007 Mar;102(3):642-53. doi: 10.1111/j.1572-0241.2006.00998.x. Am J Gastroenterol. 2007. PMID: 17156134 Review.

9

Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.

Rubenstein JH, Scheiman JM, Sadeghi S, Whiteman D, Inadomi JM. Rubenstein JH, et al. Among authors: inadomi jm. Am J Gastroenterol. 2011 Feb;106(2):254-60. doi: 10.1038/ajg.2010.470. Epub 2010 Dec 7. Am J Gastroenterol. 2011. PMID: 21139576 Free PMC article.

10

Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release.

Fass R, Inadomi J, Han C, Mody R, O'Neil J, Perez MC. Fass R, et al. Clin Gastroenterol Hepatol. 2012 Mar;10(3):247-53. doi: 10.1016/j.cgh.2011.11.021. Epub 2011 Dec 7. Clin Gastroenterol Hepatol. 2012. PMID: 22155561 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page